Search results
Results from the WOW.Com Content Network
IQVIA, formerly Quintiles and IMS Health, Inc., [6] is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research.
In 1994, he took Quintiles public through an IPO. [6] Quintiles is the "largest global provider of clinical trials and commercial marketing services to the pharmaceutical and biotechnology industry". [5] In December 2015, Gillings retired as executive chairman of Quintiles, but remains a director. [6]
Merck Serono and Quintiles Announce Innovative Clinical Development Partnership Agreement Creates Unique Strategic Collaboration for Development and Clinical Trial Execution RESEARCH TRIANGLE PARK ...
In May 2016, the company announced it would merge with Quintiles [21] [22] IMS Health shareholders received 0.384 shares of Quintiles common stock for each share of IMS Health common stock they held, leaving the split of ownership at 51.4% IMS and 48.6% Quintiles.
For premium support please call: 800-290-4726 more ways to reach us
Quintiles Named Preferred Provider in Phase I Market Report RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Quintiles is the preferred Phase I service provider and most frequently cited as the ...
The DRKS is an open access, free of charge online register for clinical trials and is available both in English and German. DRKS is part of the WHO's ICTRP. The DRKS works with two partner registries in Germany, DeReG (German Registry for Somatic Gene-Transfer Trials) and Clinical Trial Registry of the University Medical Center Freiburg. [4]
Quintiles to Acquire Novella Clinical Acquisition bolsters Quintiles' small biopharma, oncology and medical device capabilities RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- To stay ahead of the ...